Institutional members access full text with Ovid®

Share this article on:

The cholesterol ester transfer protein inhibitor, anacetrapib

Jialal, Ishwarlal; Kaur, Jaspreet

Section Editor(s): Rees, Alan

Current Opinion in Lipidology: June 2011 - Volume 22 - Issue 3 - p 245–246
doi: 10.1097/MOL.0b013e3283474ce1
Bimonthly update: Edited by Alan Rees

Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, Sacramento, California, 95817 and VA Medical Center, Mather, California, 95655, USA

Correspondence to Ishwarlal Jialal, Laboratory for Atherosclerosis and Metabolic Research, University of California Davis Medical Center, Sacramento, California and VA Medical Center, Mather, CA, USA Tel: +1 916 734 6590; fax: +1 916 734 6593; e-mail: ishwarlal.jialal@ucdmc.ucdavis.edu

© 2011 Lippincott Williams & Wilkins, Inc.